Total Payments
$184,240
2024 Payments
$15,456
Companies
19
Transactions
191
Medicare Patients
1,131
Medicare Billing
$197,354
Payment Breakdown by Category
Other$107,342 (58.3%)
Consulting$43,751 (23.7%)
Travel$29,187 (15.8%)
Food & Beverage$3,961 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $104,242 | 33 | 56.6% |
| Consulting Fee | $43,751 | 14 | 23.7% |
| Travel and Lodging | $29,187 | 76 | 15.8% |
| Food and Beverage | $3,961 | 66 | 2.1% |
| Honoraria | $3,100 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Verastem, Inc. | $51,032 | 61 | $0 (2020) |
| Incyte Corporation | $41,846 | 46 | $0 (2022) |
| BeiGene USA, Inc. | $28,288 | 25 | $0 (2024) |
| ADC Therapeutics America, Inc. | $16,121 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,780 | 1 | $0 (2018) |
| Seagen Inc. | $7,731 | 12 | $0 (2023) |
| Genentech USA, Inc. | $7,510 | 11 | $0 (2024) |
| GENZYME CORPORATION | $5,178 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $5,119 | 6 | $0 (2024) |
| Lilly USA, LLC | $3,600 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,456 | 24 | Genentech USA, Inc. ($7,510) |
| 2023 | $19,689 | 16 | BeiGene USA, Inc. ($9,983) |
| 2022 | $52,656 | 56 | Incyte Corporation ($30,585) |
| 2021 | $23,303 | 26 | Incyte Corporation ($11,261) |
| 2020 | $19,127 | 19 | Verastem, Inc. ($6,303) |
| 2019 | $46,228 | 49 | Verastem, Inc. ($44,728) |
| 2018 | $7,780 | 1 | AstraZeneca Pharmaceuticals LP ($7,780) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $76.68 | General |
| Category: Oncology | ||||||
| 12/07/2024 | BeiGene USA, Inc. | BRUKINSA (Drug), TEVIMBRA | Food and Beverage | In-kind items and services | $90.51 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: BioOncology | ||||||
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $276.64 | General |
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $66.05 | General |
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $64.00 | General |
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $61.44 | General |
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $49.00 | General |
| 10/04/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $39.00 | General |
| 09/10/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $582.14 | General |
| 05/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: BioOncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Travel and Lodging | In-kind items and services | $1,233.65 | General |
| Category: BioOncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Travel and Lodging | In-kind items and services | $281.00 | General |
| Category: BioOncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Food and Beverage | In-kind items and services | $147.54 | General |
| Category: BioOncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: BioOncology | ||||||
| 05/01/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Food and Beverage | Cash or cash equivalent | $45.88 | General |
| Category: BioOncology | ||||||
| 04/12/2024 | Genentech USA, Inc. | Lunsumio (Biological), Columvi | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,280.00 | General |
| Category: BioOncology | ||||||
| 03/13/2024 | Genentech USA, Inc. | Polivy (Biological), Lunsumio | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,080.00 | General |
| Category: BioOncology | ||||||
| 03/13/2024 | Genentech USA, Inc. | Polivy (Biological), Lunsumio | Travel and Lodging | In-kind items and services | $656.52 | General |
| Category: BioOncology | ||||||
| 03/13/2024 | Genentech USA, Inc. | Polivy (Biological), Lunsumio | Food and Beverage | In-kind items and services | $89.33 | General |
| Category: BioOncology | ||||||
| 03/08/2024 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 02/21/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $40.97 | General |
| 01/25/2024 | BTG International, Inc. | VORAXAZE (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 12/11/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $57.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 314 | 513 | $148,530 | $43,984 |
| 2022 | 6 | 240 | 511 | $126,475 | $41,271 |
| 2021 | 6 | 318 | 721 | $181,075 | $62,924 |
| 2020 | 6 | 259 | 621 | $154,060 | $49,175 |
Total Patients
1,131
Total Services
2,366
Medicare Billing
$197,354
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 163 | $52,160 | $14,908 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 80 | $17,600 | $5,897 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 53 | $16,430 | $5,819 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 61 | $18,655 | $5,749 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 101 | $21,920 | $5,729 | 26.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $11,845 | $3,071 | 25.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 30 | 32 | $9,920 | $2,811 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 115 | 260 | $52,120 | $17,441 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 34 | 82 | $23,640 | $9,239 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 118 | $30,680 | $8,540 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $8,500 | $2,500 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $6,500 | $2,201 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 19 | $5,035 | $1,351 | 26.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 281 | $73,060 | $23,067 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 111 | 265 | $51,675 | $19,432 | 37.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 42 | 82 | $22,650 | $9,367 | 41.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 41 | 46 | $12,190 | $3,816 | 31.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 23 | $11,500 | $3,671 | 31.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 24 | 24 | $10,000 | $3,571 | 35.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 56 | 218 | $55,590 | $18,171 | 32.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 93 | 281 | $54,795 | $16,930 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 33 | $16,170 | $5,282 | 32.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $10,660 | $3,553 | 33.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 30 | 32 | $8,320 | $2,708 | 32.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 24 | 31 | $8,525 | $2,530 | 29.7% |
About Dr. Narendranath Epperla, MD
Dr. Narendranath Epperla, MD is a Internal Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1902119019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Narendranath Epperla, MD has received a total of $184,240 in payments from pharmaceutical and medical device companies, with $15,456 received in 2024. These payments were reported across 191 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($104,242).
As a Medicare-enrolled provider, Epperla has provided services to 1,131 Medicare beneficiaries, totaling 2,366 services with total Medicare billing of $197,354. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology
- Location Columbus, OH
- Active Since 07/17/2010
- Last Updated 12/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902119019
Products in Payments
- Copiktra (Drug) $51,032
- MONJUVI (Drug) $41,846
- BRUKINSA (Drug) $28,288
- ADCETRIS (Biological) $7,565
- Lunsumio (Biological) $5,644
- KYMRIAH (Drug) $3,452
- Polivy (Biological) $1,826
- XPOVIO (Drug) $1,625
- Imbruvica (Drug) $1,500
- TAZVERIK (Drug) $1,475
- KYMRIAH (Biological) $655.00
- VORAXAZE (Drug) $542.80
- Columvi (Biological) $39.72
- Epkinly (Drug) $20.52
- RYBELSUS (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbus
Anish Amin, M.d, M.D
Internal Medicine — Payments: $807,022
Internal Medicine $807,022
Dr. Alexa Meara, Md, MD
Internal Medicine — Payments: $377,655
Internal Medicine $377,655
Jayanta Mukherjee, Md, MD
Internal Medicine — Payments: $240,062
Internal Medicine $240,062
Dr. David Lo, M.d, M.D
Internal Medicine — Payments: $185,475
Internal Medicine $185,475
Lucy Laperna, Do, DO
Internal Medicine — Payments: $133,632
Internal Medicine $133,632
Carlos Malvestutto, M.d, M.D
Internal Medicine — Payments: $107,580
Internal Medicine $107,580